These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations.
    Author: Mertens T, Tondorf G, Siebolds M, Kruppenbacher JP, Shrestha SM, Mauff G, Gürtler L, Eggers HJ.
    Journal: Infection; 1989; 17(1):4-7. PubMed ID: 2921088.
    Abstract:
    401 sera from patients of a rural hospital in Zimbabwe (1987), 211 South African sera (1982/83), as well as 460 sera from four Katmandu hospitals (1985) were tested for HIV-1 antibodies. The sera from Zimbabwe and Nepal were additionally tested for anti-HIV-2 using a panel of different tests, for hepatitis B markers, and partially for antibodies against other viral, bacterial, and protozoal antigens. Detailed clinical and sociodemographic data were taken from the Zimbabwe and Katmandu patients. The prevalence of HIV-1 antibodies in the Zimbabwe study population was 3.2%. All infections were found in the age group 17 to 30 years (n = 254). The epidemiological situation was entirely different from that of HBV (hepatitis B virus). No serum could be confirmed to be anti-HIV-2-positive, but a definite diagnosis is still difficult to establish. Regular town contacts may be considered a possible risk factor. Antibodies against HIV-1 could not be detected in the South African and Asian sera. The seropositivity for anti-HBc in Katmandu (14%) and the prevalence of HBsAg (1.1%) was much lower than reported from other Asian countries. 401 sera from patients in a rural hospital in Zimbabwe (1987), 211 South African sera (1982-83), as well as 460 sera from 4 Kathmandu hospitals (1985) were tested for HIV-1 antibodies. The sera from Zimbabwe and Nepal were additionally tested for anti-HIV-2 using a panel of different tests for hepatitis B markers and partially for antibodies against other viral, bacterial, and protozoal antigens. Detailed clinical and sociodemographic data were taken from the patients in both groups. The prevalence of HIV-1 antibodies in the Zimbabwe study population was 3.2%. All infections were found in the 17-30 year age group (n=254). The epidemiological situation was entirely different from that of HBV (hepatitis B virus). No serum could be confirmed to be anti-HIV-2- positive, but a definite diagnosis is still difficult to establish. Regular town contracts may be considered a possible risk factor. Antibodies against HIV-1 could not be detected in the South African and Asian sera. The seropositivity for anti-HBc in Kathmandu (14%) and the prevalence of HBsAg (1.1%) was much lower than reported from other Asian countries. (author's modified)
    [Abstract] [Full Text] [Related] [New Search]